DNS 3379

Drug Profile

DNS 3379

Alternative Names: DNS-3379

Latest Information Update: 11 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dart NeuroScience
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Stroke

Most Recent Events

  • 01 Oct 2017 Phase-II clinical trials in Stroke in Australia (unspecified route) (NCT03254160)
  • 22 Aug 2017 Preclinical trials in Stroke in USA (unspecified route)
  • 22 Aug 2017 Dart NeuroScience plans phase II SPIRIT trial for Stroke in 2017 (NCT03254160 )
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top